Association of GLP-1 receptor agonists with risk of intestinal obstruction in patients with type 2 diabetes mellitus: a retrospective cohort study.

Acta Diabetol · 2025 · PMC12640328 · PMID 40471297

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

However, another analysis based on data from three European countries did not confirm this signal, suggesting that the increased risk associated with GLP-1RAs may not be significant compared to SGLT-2 inhibitors among T2DM patients [ 16 ].

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.